Release Date: November 2018
Available for CMLE Only
Nils B. Person, PhD, FACB
Senior Clinical Consultant, Siemens Healthineers, Tarrytown, NY
This course will assist laboratory staff deal with the challenges associated with starting a new reagent lot such as QC results shifting and verifying the performance of a new reagent lot. The EP26 CLSI published guidelines for User Evaluation of Between-Reagent Lot Variation provide a practical solution to this common issue. These protocols will be reviewed in an effort to provide guidance on best practices.
After attending this session, participants will be able to:
- Discuss the challenges of evaluating a new reagent lot.
- Describe the impact of QC sample matrix on evaluating new reagent lots.
- Highlight the guidelines provided in the CLSI EP26 document for evaluating a new reagent lot.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians